Search for: "AMGEN INC."
Results 1 - 20
of 702
Sort by Relevance
|
Sort by Date
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
22 May 2024, 10:00 pm
Its decision underscores the strategic advantage of employing means-plus-function limitations in cases where genus claims are not practicable or otherwise subject to attack under the Supreme Court’s reasoning in Amgen Inc. v. [read post]
17 May 2024, 9:37 pm
Although not directly related, the Supreme Court’s May 18, 2023 decision in Amgen v. [read post]
30 Apr 2024, 7:30 am
Amgen Inc. v. [read post]
26 Apr 2024, 12:41 pm
by Dennis Crouch I was rereading the Supreme Court’s recent enablement decision of Amgen Inc. v. [read post]
23 Apr 2024, 10:28 am
See, Amgen Inc. v. [read post]
27 Mar 2024, 4:46 pm
Amgen Inc. v. [read post]
27 Mar 2024, 10:56 am
The 2019 decision Amgen Inc. v. [read post]
25 Jan 2024, 6:32 am
The FTC also touted its settlement of the Amgen/Horizon matter (here and here) although, as I explained in December, the core of the consent order—reached on the eve of trial—had been proposed by Amgen all along. [read post]
23 Jan 2024, 3:43 am
Vanda Pharmaceuticals Inc., v. [read post]
21 Jan 2024, 9:01 pm
In Seven & i Holdings Co., Ltd. and 7-Eleven, Inc. [read post]
18 Jan 2024, 5:14 pm
Share on LinkedInShare on TwitterShare by EmailShare Back to top The USPTO has issued “Guidelines for Assessing Enablement in Utility Applications and Patents in View of the Supreme Court Decision in Amgen Inc. et al. v. [read post]
11 Jan 2024, 12:59 pm
Genentech, Inc., 81 F.4th 1362 (Fed. [read post]
4 Jan 2024, 9:42 am
SweeGen, Inc., No. 22-1946 (Fed. [read post]
31 Dec 2023, 4:29 pm
Enablement Amgen v. [read post]
20 Dec 2023, 5:00 am
Monoclonal Antibodies Inc., 1985) protected large genus claims. [read post]
